Ambrose Healthcare Exercise Option on VAL 401 Out License Agreement for £16 Million plus Royalties
ValiRx PLC (AIM:VAL) Conclusion of Evaluation Project
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, provides the following update at the conclusion of the Evaluation project from
RNS Hotlist with Zak Mir: RDSB, FRG, KZG, ABDX, COG, VAL, GMET, MKA & LIKE
The Times reported that investors pulled a net £9.6 billion from UK funds last year, according to data from Calastone. It was the ninth consecutive year of net outflows, and although
Share Talk Weekly Stock Market News Review, Sunday 5th January 2025
On Friday, gold continued its upward momentum, bolstering a robust start to the year. By late morning, the precious metal was priced at US$2,657 per ounce, reflecting a daily increase
RNS Hotlist with Zak Mir: PLSR, HE1, VAL, DGI, CTL, ZPHR, GLR & PALM
Pulsar Helium (PLSR), a helium project development company, announced that it is arranging a brokered private placement to select US based investors at a price of US$0.38 (equivalent to approximately C$0.55
ValiRx PLC (AIM:VAL) Update on proposed sub-license of VAL201
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health announces that, further to the amendment to the Letter of Intent (“LOI”)
Trader’s Café With Zak Mir: The Week In Small Caps, Sunday 15th December 2024
London 0 Oman 1 Given the way that Bloomberg announced this week that London has fallen below Oman and Malaysia in the IPO rankings, it is perhaps the case that
ValiRx PLC (AIM:VAL) Update on proposed sub-license of VAL201
Update on proposed sub-license of VAL201
RNS Hotlist with Zak Mir: IMM, INC, SYM, EUA, BBSN, VOY, EQT, EDX, EGT, AVCT, ONC, ELEG, RBG, UKOG, ATM, SNDA, CTL, ROCK, UPL, KAT, CIZ & VAL
ImmuPharma (IMM), the specialist drug discovery and development company, announced its interim results for the six months ended 30 June 2024. On 3 June 2024. ImmuPharma divested its investment in shares
RNS Hotlist with Zak Mir: HE1, BNL, JLP, UFO, PAT, RGT, CYK, POLB, HUM, INC, VAL, BELL, BZT, GROC, CTL, HUI, UOG, POW & GMET
Helium One Global (HE1), the primary helium explorer in Tanzania, announced that the Company has entered into a conditional binding heads of agreement pursuant to which Helium One has agreed to
RNS Hotlist with Zak Mir: EDEN, CRTM, CRCL, KEFI, ACRM, IES, VAL, HEMO, CGO, MNRG, FMET, PAT, CIZ, NFX & LEX
Eden Research (EDEN), the AIM-quoted company focused on sustainable biopesticides, announced that it has been named ESG Company of the Year at the prestigious 2024 Small Cap Network Awards in recognition
ValiRx PLC (AIM:VAL) Business Update
ValiRx plc (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women’s health, is today pleased to provide an operational update.